Procter & Gamble Co (NYSE: PG) Q2 2021 earnings call dated Jan. 20, 2021
Corporate Participants:
Jon R. Moeller — Vice Chairman, Chief Operating Officer and Chief Financial Officer
Analysts:
Lauren Lieberman — Barclays — Analyst
Steve Powers — Deutsche Bank — Analyst
Olivia Tong — Bank of America — Analyst
Dara Mohsenian — Morgan Stanley — Analyst
Kevin Grundy — Jefferies — Analyst
Jason English — Goldman Sachs — Analyst
Wendy Nicholson — Citigroup — Analyst
Nik Modi — RBC — Analyst
Rob Ottenstein — Evercore — Analyst
Andrea Teixeira — JP Morgan. — Analyst
Mark Astrachan — Stifel — Analyst
Kaumil Gajrawala — Credit Suisse — Analyst
Chris Carey — Wells Fargo — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Listen On
